M12 — M1 Kliniken AG Income Statement
0.000.00%
Last trade - 00:00
- €258.31m
- €224.90m
- €285.29m
- 78
- 38
- 95
- 84
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 65.2 | 77.2 | 160 | 315 | 285 |
Cost of Revenue | |||||
Gross Profit | 22.9 | 31.6 | 36.8 | 55.3 | 52.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 58.8 | 69.3 | 155 | 302 | 276 |
Operating Profit | 6.46 | 7.95 | 4.41 | 12.1 | 9.35 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.09 | 12.8 | 8.78 | 14.4 | 10.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.61 | 9.73 | 7.42 | 10.9 | 7.07 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 6.61 | 9.73 | 6.82 | 8.91 | 4.32 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6.61 | 9.73 | 6.82 | 8.91 | 4.32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.393 | 0.556 | 0.366 | 0.453 | 0.219 |
Dividends per Share |